Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002570420 | SCV003293949 | uncertain significance | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2022-05-18 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 522 of the TERT protein (p.Arg522Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with acute myeloid leukemia (PMID: 19147845). ClinVar contains an entry for this variant (Variation ID: 973675). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TERT protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on TERT function (PMID: 19796246, 23901009). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001267799 | SCV005052989 | uncertain significance | Dyskeratosis congenita, autosomal dominant 2 | 2023-11-30 | criteria provided, single submitter | clinical testing | |
UOSD Laboratory of Genetics & Genomics of Rare Diseases, |
RCV001267799 | SCV001424117 | uncertain significance | Dyskeratosis congenita, autosomal dominant 2 | 2020-05-21 | no assertion criteria provided | clinical testing |